D. Thaçi, “Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials”, Acta Derm Venereol, vol. 106, pp. adv–2025, May 2026.